Peter Switzer is joined by Ron Shamgar of TAMIM Asset Management, Raymond Chan of Morgans, and Paul Ryan of PropTrack.

Peter Switzer talks with EMVision (EMV) CEO, Ron Weinberger.

David Stamler of Alterity Therapeutics speaks at the Switzer Small and Micro Cap Investor Strategy Day 2022.

Peter Switzer and Paul Rickard share their thoughts on the major current affairs impacting financial markets and the economy.

Peter Switzer is joined by Jun Bei Liu of Tribeca Alpha Plus, Michael Gable of Fairmont Equities, and Paul Rickard from the Switzer Report.

Dr Ross looks at the possible advantages and disadvantages between having A1 and A2 milk.

Peter Switzer is joined by Chris Joye of Coolabah Capital and the AFR, Dan Annan of Cosmos Asset Management, and Lloyd Edge of Aus Property Professionals.

Peter Switzer is joined by Paul Rickard from the Switzer Report, Adam Dawes of Shaw & Partners, and Chris Joye of Coolabah Capital and the AFR.

Recently a medical item came out with the headline, 'Dairy products increase cancer risk'. Dr Ross analyses this study and gives his insight on the topic.

Peter Switzer is joined by Rudi Filapek-Vandyck of FNArena, Kelli Meagher of Sage Capital, and commercial property specialist Helen Tarrant.

Peter Switzer and Paul Rickard share their thoughts on the major current affairs impacting financial markets and the economy.

Peter Switzer is joined by Paul Rickard from the Switzer Report, Shane Oliver of AMP Capital, and Chief Economist of Morgans, Michael Knox.